NICE recommends acamprosate, naltrexone, and disulfiram for maintaining abstinence, and nalmefene for reducing consumption in specific patient groups
Any savings on health spending because of obesity drugs may take many years and may not accrue to the Medicaid program if individuals experience shifts in coverage, so states may not be factoring long-term savings into coverage decisions
Likewise, individuals taking medications that affect gastric motility or nausea (e.g., metoclopramide, ondansetron) may need coordinated timing strategies
Reviewed by: Sloane Stoklosa, UGA Dietetic Intern References Brantster, A
and IL-6, mitigating the chronic low-grade inflammation (inflammaging) that contributes to tissue breakdown and cellular senescence
NMR approaches that rely on residual dipolar couplings (RDC) 26 demand finding compatible orienting media, solid-state NMR requires substantial protein quantities